OASIS extracellular matrix clinical efficacy study

OASIS extracellular matrix clinical efficacy study - OASIS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026039

Enrollment

Registered

2017-03-01

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patient having donor site for split-thickness skin graft

Interventions

half side test of extracellular matrix and conventional treatment for split thickness donor site. the term of intervention is until healing of donor site. biopsy of donor sites applied OASIS and con

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients having split thickness donor site

Exclusion criteria

Exclusion criteria: infectious wound

Design outcomes

Primary

Measure	Time frame
pathologic evaluation of donor site after healing	—

Secondary

Measure	Time frame
time to healing	—

Countries

Japan

Contacts

Public Contactyutaro yamashita

kyorin university hospital plastic surgery

thestarstripjp@yahoo.co.jp0422-47-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026